Why Clinuvel, De Grey, and Advance NanoTek are soaring higher today

On a day that's seen another sea of red across the S&P/ASX 200 Index (INDEXASX:XJO), here are 3 ASX shares that are shining lights today.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On a day that's seen another sea of red across the S&P/ASX 200 Index (INDEXASX: XJO), here are 3 ASX shares that are shining lights today.

Advance Nanotek Ltd (ASX: ANO)

The Advance Nanotek share price is trading 4.2% higher at the time of writing following an ASX announcement containing several updates yesterday afternoon.

Yesterday, the company reported it has started investigations into a possible capital reduction which may go ahead before the end of FY20. Additionally, in a profitability update, the company noted it recorded just over $1 million profit before tax for the month of February 2020. Along with this, the company added that its operations remain debt-free, and it has in excess of $1.9 million in the bank.

On top of these updates, the company also announced the signing of a new distribution agreement. Deveraux Specialties is to be Advance NanoTek's non-exclusive distributor for Canada. Advance Nanotek is aiming to grow its Canadian operations over the next year, as it has recently done in the US.

In addition, the company provided an update with regards to the potential impact of the coronavirus. Despite receiving 'concerning' feedback from its US distributor, Advance NanoTek believes its product will continue to experience demand.

Clinuvel Pharmaceuticals Limited (ASX: CUV)

The Clinuvel share price has surged higher today by 5.1% at the time of writing. Today's increase appears to be linked to an ASX release earlier in the week.

On Tuesday, Clinuvel announced it had secured a meeting with the US Food and Drug Administration (FDA) to progress the use of its drug, SCENESSE, for the treatment of vitiligo. The disease is a skin disorder characterised by the appearance of white to off-white skin patches in different parts of the body due to the loss of melanin production.

Pending ongoing safety and efficacy of its vitiligo program, Clinuvel will seek to file a supplemental New Drug Application for SCENESSE. The Clinuvel share price rocketed as much as 25% on the day of the announcement. After slightly dipping yesterday, this momentum appears to be pushing shares higher today.

De Grey Mining Limited (ASX: DEG)

The De Grey Mining share price is up by 3.04% today at the time of writing. Today's rise comes on the back of a massive 24.3% gain yesterday after the company announced results from drilling programs at the newly discovered Hemi Prospect. In early trade yesterday, De Grey Mining shares climbed as much as 44.44% higher.

According to yesterday's release, the company's recent drilling has revealed wide, continuous, and high-quality grade gold mineralisation. De Grey Mining believes this confirms a large-scale gold system at Hemi.

Additionally, the company believes that the significant sulphide zones beneath the high-grade gold zones are very encouraging, and the large sulphide zones have the potential to significantly increase Hemi's scale.

Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Advance NanoTek Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

rising asx share price represented by rollercoaster ride climbing higher
Broker Notes

2 ASX All Ords shares tipped to rip 20% to 85% in 2026

Here are 2 ASX All Ords shares that the experts predict will grow strongly in the new year.

Read more »

Army man and woman on digital devices.
Broker Notes

Bell Potter names the best ASX defence stocks to buy

Wanting exposure to this booming industry? Bell Potter has two picks for you.

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Opinions

These 2 great ASX shares are bargain buys!

These stocks look really cheap to me and could deliver big returns.

Read more »

A little Asian girl is so excited by the bubbles coming out of her bubble machine.
Broker Notes

Wondering which ASX shares to buy for 2026? Experts weigh in

We reveal 4 ASX shares with buy recommendations from the experts.

Read more »

A man closesly watch a clock, indicating a delay or timing issue on an ASX share price movement
Opinions

2 magnificent ASX stocks to own for the long haul

I think these stocks will keep delivering for years.

Read more »

A businesswoman in a suit and holding a briefcase marches higher as she steps from one stack of coins to the next.
Opinions

3 great ASX shares I'm buying to become a millionaire

I’m backing these investments in a big way.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Broker Notes

These ASX 200 shares could rise 50% to 65%

Big things could be coming for buyers of these shares according to analysts.

Read more »

Higher interest rates written on a yellow sign.
Broker Notes

How will interest rate hikes impact the big four ASX banks like CBA shares?

If the RBA hikes interest rates in 2026, what will that mean for ANZ, Westpac, NAB, and CBA shares?

Read more »